A new trading day began on Friday, with Lexeo Therapeutics Inc (NASDAQ: LXEO) stock price down -2.31% from the previous day of trading, before settling in for the closing price of $5.19. LXEO’s price has ranged from $4.78 to $22.33 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 19.69%. Meanwhile, its annual earnings per share averaged 74.84%. With a float of $23.58 million, this company’s outstanding shares have now reached $33.06 million.
Considering the fact that the conglomerate employs 58 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Lexeo Therapeutics Inc (LXEO) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Lexeo Therapeutics Inc is 28.69%, while institutional ownership is 73.96%. The most recent insider transaction that took place on Dec 10 ’24, was worth 20,491. In this transaction Chief Executive Officer of this company sold 2,500 shares at a rate of $8.20, taking the stock ownership to the 120,695 shares. Before that another transaction happened on Dec 10 ’24, when Company’s Director proposed sale 2,500 for $8.24, making the entire transaction worth $20,600.
Lexeo Therapeutics Inc (LXEO) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 74.84% per share during the next fiscal year.
Lexeo Therapeutics Inc (NASDAQ: LXEO) Trading Performance Indicators
Here are Lexeo Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.95.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.84, a number that is poised to hit -0.81 in the next quarter and is forecasted to reach -3.01 in one year’s time.
Technical Analysis of Lexeo Therapeutics Inc (LXEO)
Compared to the last year’s volume of 0.23 million, its volume of 0.26 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 10.26%. Additionally, its Average True Range was 0.61.
During the past 100 days, Lexeo Therapeutics Inc’s (LXEO) raw stochastic average was set at 3.84%, which indicates a significant decrease from 10.07% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 70.78% in the past 14 days, which was lower than the 89.80% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.97, while its 200-day Moving Average is $11.11. Nevertheless, the first resistance level for the watch stands at $5.29 in the near term. At $5.51, the stock is likely to face the second major resistance level. The third major resistance level sits at $5.73. If the price goes on to break the first support level at $4.85, it is likely to go to the next support level at $4.63. Now, if the price goes above the second support level, the third support stands at $4.41.
Lexeo Therapeutics Inc (NASDAQ: LXEO) Key Stats
With a market capitalization of 167.64 million, the company has a total of 33,066K Shares Outstanding. Currently, annual sales are 0 K while annual income is -66,390 K. The company’s previous quarter sales were 0 K while its latest quarter income was -29,490 K.
